TumCP Cancer Research Results
TumCP, Tumor Cell proliferation: Click to Expand ⟱
| Source: |
| Type: |
Tumor cell proliferation is a key characteristic of cancer. It refers to the rapid and uncontrolled growth of cells that can lead to the formation of tumors.
|
Nor, Normal Healthy: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
*TumCP↓, *ROS↑, *eff↓, *MDA↑, *GSH↓, *MMP↓, *ATP↓, *LC3II↑, *p62↑, *Bcl-2↓, *BAX↑, *Casp3↑,
| - |
vitro+vivo, |
ESCC, |
TE1 |
|
|
|
- |
vitro+vivo, |
ESCC, |
KYSE-510 |
|
|
|
- |
in-vitro, |
Nor, |
Het-1A |
|
|
|
TumCP↓, LC3‑Ⅱ/LC3‑Ⅰ↑, p62↓, p‑AMPK↑, mTOR↓, TumAuto↑, NCOA4↑, MDA↑, Iron↑, TumW↓, TumVol↓, ATG5↑, ATG7↑, TfR1/CD71↓, FTH1↓, ROS↑, Iron↑, Ferroptosis↑, *toxicity↓,
| - |
in-vitro, |
Nor, |
3T3 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
CRC, |
HT-29 |
|
|
|
Thiols↓, tumCV↓, TumCP↓, GSH↓, GSSG↑, ROS↑,
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
Nor, |
HUVECs |
|
|
|
- |
in-vivo, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
BC, |
T47D |
|
|
|
- |
in-vitro, |
BC, |
BT549 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-361 |
|
|
|
TumCP↓, COX2↓, *angioG↓, Cyt‑c↑, CREB2↓, cFos↓, NF-kB↓, HATs↓, cl‑Casp3↑, cl‑Casp9↑, Bax:Bcl2↑, Apoptosis↑, *toxicity↓,
| - |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Nor, |
BEAS-2B |
|
|
|
- |
in-vitro, |
Lung, |
H1975 |
|
|
|
TumCP↓, Apoptosis↑, TumCMig↓, TumCI↓, Cyt‑c↑, MDA↑, GSH↓, ROS↑, PI3K↓, Akt↓, mTOR↓,
| - |
in-vitro, |
HCC, |
HepG2 |
|
|
|
- |
in-vitro, |
Nor, |
HL7702 |
|
|
|
Keap1↑, NRF2↓, EMT↓, TumCP↓, TumCI↓, selectivity↑, *toxicity↓, ROS↑, MDA↑, GSH↓, Ferroptosis↑,
| - |
in-vitro, |
EC, |
K1 |
|
|
|
- |
in-vitro, |
Nor, |
THESCs |
|
|
|
TumCP↓, *toxicity↓, Apoptosis↑, TumCCA↑, TumCMig↓, TumCI↓, p‑SMAD2↓, TGF-β↓, *toxicity↓,
Inflam↓, *TumCP↓, cycD1/CCND1↓, NF-kB↓, angioG↓,
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
TumCP↓, TumCMig↓, selectivity↑, *BDNF↑, *ROS↓, *TNF-α↓, *IL6↓, *IFN-γ↓, *NF-kB↓, BAX⇅, Bcl-2↓, *antiOx↑, radioP↑, ChemoSen↑,
*antiOx↑, *Inflam↓, *AntiDiabetic↓, AntiCan↑, *lipid-P↓, TumCP↓, Apoptosis↑, TumCCA↑, *SOD↑, *PGE2↓, *NO↓, *IL8↓, *IFN-γ↓, *cardioP↑, *NF-kB↓, *TNF-α↓, *BioAv↑,
| - |
in-vitro, |
Pca, |
DU145 |
|
|
|
- |
in-vitro, |
Nor, |
MEF |
|
|
|
NRF2↑, selectivity↑, NQO1↑, GCLC↑, HO-1↑, TumCP↓,
| - |
in-vitro, |
GBM, |
U87MG |
|
|
|
- |
in-vitro, |
Nor, |
HMC3 |
|
|
|
TumCG↓, TumCP↓, TumCCA↑, PCBP1↓, GSH↓, GPx4↓, Beclin-1↑, MDA↑, ACSL4↑, Casp3↑, Casp7↑, Ferroptosis↑, *toxicity↓,
| - |
in-vitro, |
GBM, |
U251 |
|
|
|
- |
in-vitro, |
GBM, |
A172 |
|
|
|
- |
in-vitro, |
Nor, |
SVGp12 |
|
|
|
TumCP↓, GPx4↓, GSH↓, HSP70/HSPA5↓, NRF2↓, MDA↑, Casp3↑, Casp7↑, Ferroptosis↑, selectivity↑,
*antiOx↑, *hepatoP↑, *RenoP↑, AntiTum↑, *glucose↝, *Inflam↓, *neuroP↑, *ROS↓, *Keap1↓, *NRF2↑, *SOD↑, *Catalase↑, *GPx↑, *GSH↑, *MDA↓, *p‑ERK↑, *GRP78/BiP↑, *CHOP↑, *GRP94↑, *Casp3↓, *Casp9↓, *HGF/c-Met↑, *TNF-α↓, *TLR4↓, *MAPK↓, *IL1β↓, *iNOS↓, TCA↓, Glycolysis↓, Bcl-2↓, BAX↑, MAPK↑, JNK↑, CSCs↓, Nanog↓, SOX2↓, CD44↓, OCT4↓, P53↑, P21↑, *SOD1↑, *AGEs↓, *GLUT2↑, *HDL↑, *Fas↓, *HMG-CoA↓, *NF-kB↓, *HO-1↓, *COX2↓, *TLR4↓, *BioAv↑, *BioAv↝, TumCP↓, TumCMig↓, TumCI↓,
| - |
vitro+vivo, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-453 |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
NF-kB↓, AntiTum↑, tumCV↓, TumCP↓, Apoptosis↑, TumCMig↓, TumCI↓, EMT↓, TumCG↓, OS↑, TumMeta↓, CD4+↑, CD8+↑, Imm↑,
*antiOx↑, *toxicity↓, *BioAv↓, *BioAv↑, *neuroP↑, *Obesity↓, *AntiCan↑, *TumCP↓, *PhotoS↑, *neuroP↑,
| - |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Nor, |
3T3 |
|
|
|
TumCCA↑, P53↑, BAX↑, Casp3↑, MMP↓, Fas↑, FasL↑, Bcl-2↓, Apoptosis↑, TumCP↓, TUNEL↑, eff↑, selectivity↑,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Nor, |
HUVECs |
|
|
|
eff↑, Dose∅, *BioAv↑, selectivity↑, TumCP↓, Casp↑, PTEN↑, TSC1↑, mTOR⇅, Akt↓, PDK1↓, E6↓, E7↓, DNAdam↑, ROS↑, *BioAv↓, *BioEnh↑, *Half-Life∅,
| - |
in-vitro, |
PC, |
PANC1 |
|
|
|
- |
in-vitro, |
PC, |
Bxpc-3 |
|
|
|
- |
in-vitro, |
Nor, |
hTERT-HPNE |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
AMPK↑, mTOR↑, UPR↑, ER Stress↑, selectivity↑, TumCP↓, PERK↑, ATF4↑, ATF6↑,
| - |
vitro+vivo, |
Nor, |
HUVECs |
|
|
|
*NF-kB↓, *p65↓, *TLR4∅, *angioG↓, *TumCP↓, *VEGF↓, *Inflam↓, *ICAM-1↓, *VCAM-1↓, *E-sel↓, *p‑JNK↓, *HO-1↑,
| - |
in-vitro, |
Nor, |
RWPE-1 |
|
|
|
- |
in-vitro, |
Pca, |
LNCaP |
|
|
|
- |
in-vitro, |
Pca, |
22Rv1 |
|
|
|
- |
in-vitro, |
Pca, |
PC3 |
|
|
|
selectivity↑, TumCMig↓, p‑Akt↓, ROS↑, CSCs↓, CD44↓, TumCP↓,
| - |
in-vitro, |
Nor, |
MCF10 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-468 |
|
|
|
- |
in-vitro, |
PC, |
Bxpc-3 |
|
|
|
TumCP↓, Apoptosis↑, eff↓, *toxicity↑, Dose?, eff↓, eff↓,
| - |
in-vitro, |
Ovarian, |
OV1369 |
|
|
|
- |
in-vitro, |
Ovarian, |
OV1946 |
|
|
|
- |
in-vitro, |
Nor, |
ARPE-19 |
|
|
|
BioAv↝, TumCP↓, GlutaM↓, Warburg↓, OCR↑, Glycolysis↓, ATP↓, BioAv↝, ROS↑,
| - |
Trial, |
BC, |
NA |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Nor, |
C2C12 |
|
|
|
TumCP↓, TumCMig↓, TumCI↓, *toxicity∅, TGF-β↓, Twist↓, Slug↓, β-catenin/ZEB1↓, Vim↓, p‑SMAD2↓, p‑SMAD3↓, angioG↓, VEGF↓, selectivity↑, LIF↑,
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
TumCP↓, MMP↓, ROS↑, eff↝, selectivity↑,
| - |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
Nor, |
FF95 |
|
|
|
TumCP↓, *toxicity↓, ChemoSen↑, RadioS↑, selectivity↑, Ca+2↑,
| - |
in-vitro, |
HCC, |
HCCLM3 |
|
|
|
- |
in-vitro, |
HCC, |
SMMC-7721 cell |
|
|
|
- |
in-vitro, |
HCC, |
Bel-7402 |
|
|
|
- |
in-vitro, |
HCC, |
HUH7 |
|
|
|
- |
in-vitro, |
HCC, |
HepG2 |
|
|
|
- |
in-vitro, |
Nor, |
L02 |
|
|
|
TumCP↓, TumCCA↓, Apoptosis↑, GlucoseCon↓, lactateProd↓, PKM2↓, Glycolysis↓, HK2↓, PFK↓, OXPHOS↑, ChemoSen↑, HSP90↓, Hif1a↓,
| - |
in-vitro, |
HCC, |
HCCLM3 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
- |
in-vitro, |
HCC, |
Bel-7402 |
|
|
|
- |
in-vitro, |
HCC, |
SMMC-7721 cell |
|
|
|
- |
in-vitro, |
Nor, |
L02 |
|
|
|
Glycolysis↓, Apoptosis↑, TumCP↓, lactateProd↓, GlucoseCon↓, HK2↓, ChemoSen↑, *toxicity↓, cMyc↓, PFK1↓, LDHA↓, cMyc↓, ChemoSen↑,
*Diff↑, *TumCP↓, *TumCCA↑, *ROS↑, *Casp3↑, *TNF-α↑,
| - |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
TXNIP↑, Casp3↑, Casp7↑, mt-ROS↑, GlucoseCon↓, TumCP↓, TumCD↑, IGF-2↑, HDAC↓, ROS⇅,
*Inflam↓, *COX2↓, *ROS↓, *NO↓, *NF-kB↓, TumCP↓, angioG↓, VEGF↓, STAT↓, Hif1a↓, RenoP↑, TLR4↓, *MDA↓, *GSH↑, *SOD↑, *Catalase↑, *toxicity∅,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Nor, |
HaCaT |
|
|
|
DNAdam↑, Apoptosis↑, ChemoSen↑, ROS↑, mt-ROS↑, Casp↑, Casp3↑, selectivity↑, TumCP↓, tumCV↓, eff↓,
| - |
in-vitro, |
GC, |
SNU16 |
|
|
|
- |
in-vitro, |
Nor, |
GES-1 |
|
|
|
TumCP↓, Apoptosis↑, BAX↑, BAD↑, Cyt‑c↑, cl‑PARP↑, cl‑Casp3↑, Bcl-2↓, Bcl-xL↓, p‑PI3K↓, p‑Akt↓, Ki-67↓, toxicity↓, RadioS↑,
| - |
in-vitro, |
HCC, |
HCCLM3 |
|
|
|
- |
in-vitro, |
Nor, |
L02 |
|
|
|
- |
in-vitro, |
HCC, |
SMMC-7721 cell |
|
|
|
- |
in-vitro, |
HCC, |
Bel-7402 |
|
|
|
- |
in-vitro, |
HCC, |
HUH7 |
|
|
|
HK2↓, ChemoSen↑, other↑, Glycolysis↓, lactateProd↓, TumCP↓, Casp3↑, cl‑PARP↑, PKM2↓,
| - |
in-vitro, |
CRC, |
Caco-2 |
|
|
|
- |
in-vivo, |
Nor, |
HCEC 1CT |
|
|
|
TumCG↓, Glycolysis↓, PPP↓, ATP↑, PDH↑, Ca+2↝, TumCP↓, lactateProd↓, OCR↑, ECAR↓, *ECAR∅, *other?, cycE/CCNE↑, cycA1/CCNA1↑, TumCCA↑, cycD1/CCND1↑, OXPHOS↑,
| - |
in-vitro, |
GC, |
BGC-823 |
|
|
|
- |
in-vitro, |
GC, |
SGC-7901 |
|
|
|
- |
in-vitro, |
Nor, |
GES-1 |
|
|
|
selectivity↑, TumCP↓, TumCD↑, ROS↑, MMP↓, Casp↑, Cyt‑c↑, Endon↑, AIF↑, eff↓, ChemoSen↑, TumCCA↑, GSH/GSSG↓, lipid-P↑,
| - |
in-vitro, |
GBM, |
U87MG |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
CRC, |
HT-29 |
|
|
|
- |
in-vitro, |
Nor, |
SVGp12 |
|
|
|
Ferroptosis↑, xCT↓, GSH↓, GPx4↓, Iron↑, lipid-P↑, ROS↑, eff↓, TumCP↓, TumCD↑,
| - |
in-vitro, |
Ovarian, |
CaOV3 |
|
|
|
- |
in-vitro, |
Nor, |
WRL68 |
|
|
|
selectivity↑, TumCP↓, MMP↓, Bcl-2↓, BAX↑, ROS↑,
| - |
Analysis, |
Nor, |
NA |
|
|
|
- |
in-vivo, |
Nor, |
NA |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Nor, |
HaCaT |
|
|
|
HDAC↓, P21↑, Maspin↑, BAX↑, B2M↓, TumCCA↑, selectivity↑, *toxicity↓, TumCMig↓, TumCP↓,
| - |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
- |
in-vitro, |
Bladder, |
253J |
|
|
|
- |
in-vitro, |
Nor, |
SV-HUC-1 |
|
|
|
TumCP↓, Apoptosis↑, ER Stress↑, cl‑Casp3↑, cl‑Casp8↑, cl‑Casp7↑, cl‑PARP↑, Cyt‑c↑, PERK↑, IRE1↑, ATF6↑, p‑eIF2α↑, ATF4↑, GRP78/BiP↑, CHOP↑,
| - |
in-vitro, |
Nor, |
RAW264.7 |
|
|
|
*iNOS↓, *COX2↓, *EP2↓, TumCP↓, selectivity↑, Apoptosis↑, *chemoP↑, *Inflam↓,
Showing Research Papers: 1 to 41 of 41
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 41
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
Ferroptosis↑, 5, GCLC↑, 1, GPx4↓, 3, GSH↓, 6, GSH/GSSG↓, 1, GSSG↑, 1, HO-1↑, 1, Iron↑, 3, Keap1↑, 1, lipid-P↑, 2, MDA↑, 5, NQO1↑, 1, NRF2↓, 2, NRF2↑, 1, OXPHOS↑, 2, ROS↑, 12, ROS⇅, 1, mt-ROS↑, 2, Thiols↓, 1, xCT↓, 1,
Metal & Cofactor Biology ⓘ
FTH1↓, 1, NCOA4↑, 1, TfR1/CD71↓, 1,
Mitochondria & Bioenergetics ⓘ
AIF↑, 1, ATP↓, 1, ATP↑, 1, MMP↓, 4, OCR↑, 2,
Core Metabolism/Glycolysis ⓘ
ACSL4↑, 1, AMPK↑, 1, p‑AMPK↑, 1, ATG7↑, 1, cMyc↓, 2, ECAR↓, 1, GlucoseCon↓, 3, GlutaM↓, 1, Glycolysis↓, 6, HK2↓, 3, lactateProd↓, 4, LDHA↓, 1, PDH↑, 1, PDK1↓, 1, PFK↓, 1, PFK1↓, 1, PKM2↓, 2, PPP↓, 1, TCA↓, 1, Warburg↓, 1,
Cell Death ⓘ
Akt↓, 2, p‑Akt↓, 2, Apoptosis↑, 13, BAD↑, 1, BAX↑, 5, BAX⇅, 1, Bax:Bcl2↑, 1, Bcl-2↓, 5, Bcl-xL↓, 1, Casp↑, 3, Casp3↑, 6, cl‑Casp3↑, 3, Casp7↑, 3, cl‑Casp7↑, 1, cl‑Casp8↑, 1, cl‑Casp9↑, 1, Cyt‑c↑, 5, Endon↑, 1, Fas↑, 1, FasL↑, 1, Ferroptosis↑, 5, JNK↑, 1, MAPK↑, 1, TumCD↑, 3, TUNEL↑, 1,
Transcription & Epigenetics ⓘ
HATs↓, 1, other↑, 1, tumCV↓, 3,
Protein Folding & ER Stress ⓘ
ATF6↑, 2, CHOP↑, 1, p‑eIF2α↑, 1, ER Stress↑, 2, GRP78/BiP↑, 1, HSP70/HSPA5↓, 1, HSP90↓, 1, IRE1↑, 1, PERK↑, 2, UPR↑, 1,
Autophagy & Lysosomes ⓘ
ATG5↑, 1, Beclin-1↑, 1, LC3‑Ⅱ/LC3‑Ⅰ↑, 1, p62↓, 1, TumAuto↑, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 2, P53↑, 2, cl‑PARP↑, 3,
Cell Cycle & Senescence ⓘ
cycA1/CCNA1↑, 1, cycD1/CCND1↓, 1, cycD1/CCND1↑, 1, cycE/CCNE↑, 1, P21↑, 2, TumCCA↓, 1, TumCCA↑, 7,
Proliferation, Differentiation & Cell State ⓘ
CD44↓, 2, cFos↓, 1, CREB2↓, 1, CSCs↓, 2, EMT↓, 2, HDAC↓, 2, IGF-2↑, 1, mTOR↓, 2, mTOR↑, 1, mTOR⇅, 1, Nanog↓, 1, OCT4↓, 1, PI3K↓, 1, p‑PI3K↓, 1, PTEN↑, 1, SOX2↓, 1, STAT↓, 1, TumCG↓, 3,
Migration ⓘ
Ca+2↑, 1, Ca+2↝, 1, Ki-67↓, 1, PCBP1↓, 1, Slug↓, 1, p‑SMAD2↓, 2, p‑SMAD3↓, 1, TGF-β↓, 2, TSC1↑, 1, TumCI↓, 6, TumCMig↓, 8, TumCP↓, 36, TumMeta↓, 1, Twist↓, 1, TXNIP↑, 1, Vim↓, 1, β-catenin/ZEB1↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 3, ATF4↑, 2, Hif1a↓, 2, VEGF↓, 2,
Immune & Inflammatory Signaling ⓘ
B2M↓, 1, CD4+↑, 1, COX2↓, 1, Imm↑, 1, Inflam↓, 1, LIF↑, 1, NF-kB↓, 3, TLR4↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↝, 2, ChemoSen↑, 8, Dose?, 1, Dose∅, 1, eff↓, 6, eff↑, 2, eff↝, 1, RadioS↑, 2, selectivity↑, 16,
Clinical Biomarkers ⓘ
B2M↓, 1, E6↓, 1, E7↓, 1, Ki-67↓, 1, Maspin↑, 1,
Functional Outcomes ⓘ
AntiCan↑, 1, AntiTum↑, 2, OS↑, 1, radioP↑, 1, RenoP↑, 1, toxicity↓, 1, TumVol↓, 1, TumW↓, 1,
Infection & Microbiome ⓘ
CD8+↑, 1,
Total Targets: 171
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 4, Catalase↑, 2, GPx↑, 1, GSH↓, 1, GSH↑, 2, HDL↑, 1, HO-1↓, 1, HO-1↑, 1, Keap1↓, 1, lipid-P↓, 1, MDA↓, 2, MDA↑, 1, NRF2↑, 1, ROS↓, 3, ROS↑, 2, SOD↑, 3, SOD1↑, 1,
Mitochondria & Bioenergetics ⓘ
ATP↓, 1, MMP↓, 1,
Core Metabolism/Glycolysis ⓘ
ECAR∅, 1, glucose↝, 1, GLUT2↑, 1, HMG-CoA↓, 1,
Cell Death ⓘ
BAX↑, 1, Bcl-2↓, 1, Casp3↓, 1, Casp3↑, 2, Casp9↓, 1, Fas↓, 1, HGF/c-Met↑, 1, iNOS↓, 2, p‑JNK↓, 1, MAPK↓, 1,
Transcription & Epigenetics ⓘ
other?, 1, PhotoS↑, 1,
Protein Folding & ER Stress ⓘ
CHOP↑, 1, GRP78/BiP↑, 1, GRP94↑, 1,
Autophagy & Lysosomes ⓘ
LC3II↑, 1, p62↑, 1,
Cell Cycle & Senescence ⓘ
TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
Diff↑, 1, EP2↓, 1, p‑ERK↑, 1,
Migration ⓘ
E-sel↓, 1, TumCP↓, 5, VCAM-1↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 2, NO↓, 2, VEGF↓, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 3, ICAM-1↓, 1, IFN-γ↓, 2, IL1β↓, 1, IL6↓, 1, IL8↓, 1, Inflam↓, 5, NF-kB↓, 5, p65↓, 1, PGE2↓, 1, TLR4↓, 2, TLR4∅, 1, TNF-α↓, 3, TNF-α↑, 1,
Synaptic & Neurotransmission ⓘ
BDNF↑, 1,
Protein Aggregation ⓘ
AGEs↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 2, BioAv↑, 4, BioAv↝, 1, BioEnh↑, 1, eff↓, 1, Half-Life∅, 1,
Clinical Biomarkers ⓘ
IL6↓, 1,
Functional Outcomes ⓘ
AntiCan↑, 1, AntiDiabetic↓, 1, cardioP↑, 1, chemoP↑, 1, hepatoP↑, 1, neuroP↑, 3, Obesity↓, 1, RenoP↑, 1, toxicity↓, 10, toxicity↑, 1, toxicity∅, 2,
Total Targets: 84
Scientific Paper Hit Count for: TumCP, Tumor Cell proliferation
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:327 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page